Insider Transactions in Q3 2021 at Guardant Health, Inc. (GH)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 10
2021
|
Stanley J Meresman Director |
SELL
Open market or private sale
|
Direct |
4,934
-22.87%
|
$641,420
$130.18 P/Share
|
|
Sep 10
2021
|
Stanley J Meresman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,934
+35.43%
|
$24,670
$5.94 P/Share
|
|
Sep 09
2021
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
433
-2.92%
|
$56,290
$130.85 P/Share
|
|
Sep 01
2021
|
Ian T Clark Director |
SELL
Open market or private sale
|
Direct |
1,076
-100.0%
|
$139,880
$130.0 P/Share
|
|
Sep 01
2021
|
Ian T Clark Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,076
+50.0%
|
$4,304
$4.18 P/Share
|
|
Aug 13
2021
|
Helmy Eltoukhy Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,923
+1.28%
|
$95,692
$4.18 P/Share
|
|
Aug 13
2021
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,923
+1.35%
|
$95,692
$4.18 P/Share
|
|
Aug 10
2021
|
Stanley J Meresman Director |
SELL
Open market or private sale
|
Direct |
4,934
-54.86%
|
$562,476
$114.31 P/Share
|
|
Aug 10
2021
|
Stanley J Meresman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,934
+35.43%
|
$24,670
$5.94 P/Share
|
|
Jul 12
2021
|
Stanley J Meresman Director |
SELL
Open market or private sale
|
Direct |
4,934
-54.86%
|
$611,816
$124.27 P/Share
|
|
Jul 12
2021
|
Stanley J Meresman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,934
+35.43%
|
$24,670
$5.94 P/Share
|